Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.

Any process that stops, prevents or decreases the rate of the phosphorylation by a protein of one or more of its own residues.

Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.

Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.

Any signalling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.

Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.

Any process that modulates the frequency, rate or extent of inositol biosynthetic process.

Any process that stops, prevents or reduces the frequency, rate or extent of inositol biosynthetic process.

Any process that activates or increases the frequency, rate or extent of inositol biosynthetic process.

Any process that modulates the frequency, rate or extent of raffinose biosynthetic process.

Any process that stops, prevents or reduces the frequency, rate or extent of raffinose biosynthetic process.

Any process that activates or increases the frequency, rate or extent of raffinose biosynthetic process.

OBSOLETE. Any regulation of transcription from RNA polymerase II promoter that is involved in determination of left/right symmetry.

Any process that modulates the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.

Any process that stops, prevents or reduces the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.

Any process that activates or increases the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.

The process in which a subpopulation of granulosa cells surrounding the oocyte acquires the specialized features of an ovarian cumulus cell.

Increase in size of antral follicles due to cell proliferation and/or growth of the antral cavity.

The menstrual cycle process that results in the formation of one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells during the various stages of oogenesis.

Increase in size of follicles surrounded by two or more layers of granulosa cells up to the onset of antrum formation.